Dh. Moon et al., ACCURACY OF WHOLE-BODY FLUORINE-18-FDG PET FOR THE DETECTION OF RECURRENT OR METASTATIC BREAST-CARCINOMA, The Journal of nuclear medicine, 39(3), 1998, pp. 431-435
This study assessed the diagnostic accuracy of whole-body PET on a pat
ient and lesion basis using F-18-fluorodeoxyglucose (FDG) for the dete
ction of tumor fool in patients with suspected recurrent or metastatic
lesions of breast carcinoma. Methods: Whole-body FDG-PET imaging was
performed on 57 patients with a previous history of breast carcinoma w
ho were referred for a clinical suspicion of disease recurrence. Whole
-body PET images were scored from 1 (definitely negative) to 5 (defini
tely positive) by three independent observers, and discrepancies were
resolved by a fourth observer, Patients were clinically followed for u
p to 24 mo to assess the accuracy of PET diagnosis by biopsy, follow-u
p imaging and other diagnostic tests, Results: PET scans showed that t
here were 41 sites indicating recurrent or metastatic disease in 29 pa
tients. There were 38 sites in 28 patients that showed no evidence for
malignant disease. On a patient basis, with scores 4 or 5 considered
to be positive, sensitivity and specificity were 93% and 79%, respecti
vely, The corresponding positive and negative predictive values were 8
2% and 92%, On a lesion basis, with scores 4 or 5 considered to be pos
itive, the sensitivity was 85% and specificity 79%, The area index in
receiver operating characteristic analysis was 0.91 for patient-based
analysis and 0.88 for lesion-based analysis. To determine the cause fo
r false-negative and false-positive findings more precisely, false-neg
ative lesions with scores of 3 or lower and false-positive lesions wit
h scores of 4 or higher were analyzed, Bone metastases had a significa
ntly larger proportion Of false-negative lesions than other nonosseous
malignant sites (p < 0.05). False-positive lesions were due to muscle
uptake (n = 5), inflammation (n = 4), blood pool activity in the grea
t vessels (n = 2), bower uptake (n = 1) and unknown causes (n = 6). Co
nclusion: The whole-body FDG-PET scan is a useful diagnostic test for
detecting recurrent or metastatic lesions of breast carcinoma. However
, the sensitivity for metastases to bone appears to be lower than that
to other organs, Specificity may be improved by more strict attention
to patient preparation and better recognition of physiologic skeletal
muscle or artifactual uptakes.